+++ Current Meta Study: Brachytherapie more succesful than Radical Surgery - read more +++
The West German Prostate Center is one of the largest centers for prostate treatment in Europe. Since 2002 the Center offers the full range of diagnostics, treatments, and patient care for prostate diseases. The combination of experienced specialists under one roof, the long-standing experience, and collaborative approach allows for patient care at the highest level.
Whether you want to come for preventive treatment, unclear symptoms, or a known disease, you should always feel like you receive good advice, are treated well, and are sufficiently informed!
The focus of the Centre is the treatment of prostate cancer and benign prostatic hyperplasia with modern surgery / laser procedures, innovative techniques of brachytherapy, and external radiation therapy.
The Website of the West German Prostate Center will inform you comprehensively about prostate carcinoma und die benign prostate enlargement as well as the related examinations and possible therapies.
If you have questions, we would appreciate your contacting us.
We are looking forward to seeing you in our Center!
Results from the ProtecT-Trial show that surgery has no advantage in risk of cancer progression over time compared to radiotherapy, but causes more unpleasant side-effects.
An international panel of experts developed unique tool to support therapy decision-making in prostate cancer.
Surgery, radiotherapy or just wait and see? Prostate cancer like no other type of cancer, creates so many misconceptions, biases, and wrong information concerning the causes, treatment methods, and possible cures.
In a recently published ranking of physicians, Dr. Stephan Neubauer, Chief of Urology at the West-German Prostate Center, was again voted to be one of the best urologists in Germany
The largest trial of PSA-screening which recommends no PSA-based cancer screening, contained important errors as New England Journal of Medicine published recently.
Prostate cancer tends to be more aggressive in men with low levels of vitamin D.
New PSMA marker increases accuracy in detecting prostate cancer tumor foci and metastases even more precisely than the choline PET/CT.